What question did this study set out to answer?

This research aims to identify α-amylase inhibitors derived from Chamaedorea seifrizii for diabetes management.

May 8, 2026

Phytocomponents Derived From Naturally Growing Chamaedorea seifrizii as Novel α‐Amylase Inhibitors for Diabetes Management: In Vitro and In Silico Approach

ACAmrita ChauhanShri BM Patil Medical College ASArun Dev SharmaPunjab Institute of Medical Sciences IKInderjeet KaurPunjab Institute of Medical Sciences

Key Points

This research aims to identify α-amylase inhibitors derived from Chamaedorea seifrizii for diabetes management.
In silico ADMET analysis to assess the safety and absorption of ligand molecules.
Kinetic study determining the noncompetitive inhibition of α-amylase by CIAE and CFAE extracts.
CIAE and CFAE extracts significantly inhibit α-amylase in a noncompetitive manner.
Ligand molecules exhibited good absorption with no harmful effects in the ADMET analysis.

Abstract

. According to the results of the in silico ADMET analysis, all the ligand molecules showed good absorption and did not cause any harmful effects. In a kinetic study, CIAE and CFAE were found to inhibit α-amylase in a noncompetitive way. To best of our knowledge, this is first time study reporting bioactive chemicals from C. seifrizii extracts exhibiting anti-α-amylase potential. To validate these results, more studies utilizing clinical trials and animal models are required. This study claimed that due to richness of phytocompounds, C. seifrizii extracts may help to block the enzyme α-amylase, which leads to the creation of new drugs for diabetes.

KI fragen

Bookmark

View Full Paper